Oncogenesis:Twist1/Dnmt3a和miR186可以建立一个调节回路来控制炎症相关前列腺癌进展

2017-04-11 AlexYang MedSci原创

越来越多的证据表明炎症微环境在前列腺癌进展中有着非常关键的作用。然而,潜在的机制却不清楚。最近,研究人员利用炎症相关前列腺细胞转移模型筛选了一个重要的microRNA,miR186。miR186在转移细胞中显着的下调并且可以有效地互补转移表型。研究发现,在炎症细胞因子的刺激下,在非转移细胞中,激活的细胞核因子NF-κB/p65可以通过结合在miR186的启动子上来诱导miR186的表达,而在转移细

越来越多的证据表明炎症微环境在前列腺癌进展中有着非常关键的作用。然而,潜在的机制却不清楚。最近,研究人员利用炎症相关前列腺细胞转移模型筛选了一个重要的microRNA,miR186。

miR186在转移细胞中显着的下调并且可以有效地互补转移表型。研究发现,在炎症细胞因子的刺激下,在非转移细胞中,激活的细胞核因子NF-κB/p65可以通过结合在miR186的启动子上来诱导miR186的表达,而在转移细胞中,该通路表现为丢失。有趣的是,miR186下游靶点Twist1与NF-κB/p65通路的丢失有关。在一个新的负调控回路中,Twist1可通过结合E-box并同时招募Dnmt3a来下调miR186的表达,主要机制是通过促进miR186启动子特异性位点CpG的甲基化从而封闭NF-κB/p65的转录活性和miR186对炎症信号的响应。另外,研究人员指出,高水平的Twist1水平可触发该反馈通路并成为表观遗传学开关,并表明该机制对维持转移的和晚期的前列腺癌状态很重要。最后,研究人员指出,临床资料又进一步确认了CpG甲基化和miR186的表达水平与炎症相关的人类前列腺癌进展密切相关。

原始出处:

X Zhao, R Deng, Y Wang et al. Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression. Oncogenesis. 10 April 2017. doi:10.1038/oncsis.2017.16

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-12-11 smallant2002
  2. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-10-15 小几洁
  3. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-06-17 cy0324
  4. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-04-14 虈亣靌

    不错的方式,努力学习,刻苦专研,不断总结出来新经验。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-04-13 zjubiostat
  6. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-04-13 zsyan
  7. [GetPortalCommentsPageByObjectIdResponse(id=1930442, encodeId=c2121930442c7, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Mon Dec 11 03:19:00 CST 2017, time=2017-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1947243, encodeId=974e194e24327, content=<a href='/topic/show?id=c28d1e97056' target=_blank style='color:#2F92EE;'>#TWIST1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17970, encryptionId=c28d1e97056, topicName=TWIST1)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Sun Oct 15 08:19:00 CST 2017, time=2017-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048810, encodeId=53762048810c8, content=<a href='/topic/show?id=4363e929ad' target=_blank style='color:#2F92EE;'>#Gene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7929, encryptionId=4363e929ad, topicName=Gene)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63a4277, createdName=cy0324, createdTime=Sat Jun 17 14:19:00 CST 2017, time=2017-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187454, encodeId=90d318e45442, content=不错的方式,努力学习,刻苦专研,不断总结出来新经验。, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Fri Apr 14 21:46:36 CST 2017, time=2017-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1524499, encodeId=ea1915244999a, content=<a href='/topic/show?id=5d346162a6' target=_blank style='color:#2F92EE;'>#DNMT3A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6162, encryptionId=5d346162a6, topicName=DNMT3A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ed211606244, createdName=zjubiostat, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1558065, encodeId=b75f15580651e, content=<a href='/topic/show?id=2f1c13349e7' target=_blank style='color:#2F92EE;'>#Oncogene#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13349, encryptionId=2f1c13349e7, topicName=Oncogene)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=154614942533, createdName=zsyan, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1588235, encodeId=351d15882351c, content=<a href='/topic/show?id=1cb8e014e0' target=_blank style='color:#2F92EE;'>#ESI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7014, encryptionId=1cb8e014e0, topicName=ESI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f817593223, createdName=skhzy, createdTime=Thu Apr 13 05:19:00 CST 2017, time=2017-04-13, status=1, ipAttribution=)]
    2017-04-13 skhzy

相关资讯

神说,要有前列腺,于是就有了前列腺!

第一日,神说要有光,于是有光。第二日,神说要有空气,于是有空气。第三日,神说要有大地,于是有大地和植物。第四日,神说要有日月星辰,于是有日月星辰。第五日,神说要有飞禽走兽,于是有飞禽走兽。第六日,神说要有男和女,于是有亚当和夏娃。第七日,神说我要休息了。但是夏娃跳出来:等一下,凭什么我要做女人!神:你怎么不按套路出牌?说好的剧本是你想改就能改的!夏娃:你知道生育的痛苦吗?你知道痛经有多痛吗?神:…

Science:两个基因与前列腺癌耐药性相关

转移性前列腺癌或已经扩散到其他器官的前列腺癌是不可治愈的。 1 月 6 日,罗斯韦尔帕克癌症研究所的科学家发表在《Science》杂志上的一项新研究,已经确定了两个关键基因促进前列腺癌的发展并使其抗拒治疗。 他们的工作说明了谱系可塑性的机制和前列腺癌适应治疗的能力,并点亮了破坏甚至逆转这一致命过程的机会。使用临床前模型,科学家证明称为Rb1的肿瘤抑制基因的丧失诱导了谱系可塑性和

论前列腺炎与“啪啪啪”之间的相爱相杀

导语:患有前列腺炎,可以过性生活吗?这是前列腺炎患者最敏感的话题。前列腺炎和啪啪啪之间到底是相爱还是相杀?是每位男性都心存的疑惑。

Cancer Res:前列腺癌细胞储存胆固醇为生长提供燃料

2017年2月23日讯 /生物谷BIOON/ --科学家们很早就知道晚期前列腺癌和血液中高水平的胆固醇存在关联但是一直无法确定因果关系。最近来自杜克癌症研究所的研究人员发现癌细胞会劫持并储存胆固醇为癌细胞的生长提供动力。发现这一过程可以帮助找到控制胆固醇在肿瘤中积累的更好方法,或可改善前列腺癌病人的生存率。相关研究结果发表在国际学术期刊Cancer Research上。“前列腺癌细胞,以及

Oncogene:FOXA1可抑制前列腺癌神经内分泌的分化

神经内分泌前列腺癌(NEPC)越来越成为一种临床挑战。来源于前列腺肿瘤的神经内分泌(NE)细胞的机制到目前还很不清楚。 之前研究指出,FOXA1是叉头基因家族的一个转录因子并且参与了前列腺上皮细胞的分化。最近,研究人员通过区分表型的变化和NEPC分子标记的表达,阐释了FOXA1功能缺失促使了NE的分化。研究人员推论,这种现象是由FOXA1结合在白细胞介素8(IL-8)的启动子上来直接抑制

前列腺动脉栓塞法治疗前列腺增生多年来效果显著

(图片摘自网络)2017年3月9日 生物谷BIOON/ --根据最近在国际放射学学会2017年年度会议上的一项报告,最近三年来微创手术在治疗前列腺增大患者,减轻尿道症状方面的效果十分显著。这项囊括1000名男性的研究是关于前列腺动脉栓塞术(PAE)在针对前列腺增大症状的长期治疗效果方面最大规模的统计结果。前列腺增大,又叫良性前列腺增生(BPH),是50岁以上男性中常见的前列腺问题,其中50